elgin health (gartnavel) limited Company Information
Company Number
SC271565
Next Accounts
Dec 2025
Shareholders
bank of scotland (b g s) nominees limited
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
c/o resolis limited, exchange tower, 11th floor, edinburgh, EH3 8EG
Website
https://www.robertson.co.ukelgin health (gartnavel) limited Estimated Valuation
Pomanda estimates the enterprise value of ELGIN HEALTH (GARTNAVEL) LIMITED at £1.7m based on a Turnover of £2.4m and 0.71x industry multiple (adjusted for size and gross margin).
elgin health (gartnavel) limited Estimated Valuation
Pomanda estimates the enterprise value of ELGIN HEALTH (GARTNAVEL) LIMITED at £5.7m based on an EBITDA of £1.1m and a 5.17x industry multiple (adjusted for size and gross margin).
elgin health (gartnavel) limited Estimated Valuation
Pomanda estimates the enterprise value of ELGIN HEALTH (GARTNAVEL) LIMITED at £4.4m based on Net Assets of £2.1m and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elgin Health (gartnavel) Limited Overview
Elgin Health (gartnavel) Limited is a live company located in edinburgh, EH3 8EG with a Companies House number of SC271565. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in August 2004, it's largest shareholder is bank of scotland (b g s) nominees limited with a 100% stake. Elgin Health (gartnavel) Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Elgin Health (gartnavel) Limited Health Check
Pomanda's financial health check has awarded Elgin Health (Gartnavel) Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs


5 Strong

1 Regular

4 Weak

Size
annual sales of £2.4m, make it smaller than the average company (£3.7m)
£2.4m - Elgin Health (gartnavel) Limited
£3.7m - Industry AVG

Growth
3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (8.3%)
15% - Elgin Health (gartnavel) Limited
8.3% - Industry AVG

Production
with a gross margin of 55.6%, this company has a lower cost of product (38.1%)
55.6% - Elgin Health (gartnavel) Limited
38.1% - Industry AVG

Profitability
an operating margin of 45.5% make it more profitable than the average company (5.7%)
45.5% - Elgin Health (gartnavel) Limited
5.7% - Industry AVG

Employees
with 17 employees, this is below the industry average (22)
- Elgin Health (gartnavel) Limited
22 - Industry AVG

Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Elgin Health (gartnavel) Limited
- - Industry AVG

Efficiency
resulting in sales per employee of £143.3k, this is equally as efficient (£146k)
- Elgin Health (gartnavel) Limited
£146k - Industry AVG

Debtor Days
it gets paid by customers after 54 days, this is later than average (36 days)
54 days - Elgin Health (gartnavel) Limited
36 days - Industry AVG

Creditor Days
its suppliers are paid after 45 days, this is slower than average (33 days)
45 days - Elgin Health (gartnavel) Limited
33 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Elgin Health (gartnavel) Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 49 weeks, this is more cash available to meet short term requirements (26 weeks)
49 weeks - Elgin Health (gartnavel) Limited
26 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 89.7%, this is a higher level of debt than the average (58.7%)
89.7% - Elgin Health (gartnavel) Limited
58.7% - Industry AVG
ELGIN HEALTH (GARTNAVEL) LIMITED financials

Elgin Health (Gartnavel) Limited's latest turnover from March 2024 is £2.4 million and the company has net assets of £2.1 million. According to their latest financial statements, we estimate that Elgin Health (Gartnavel) Limited has 17 employees and maintains cash reserves of £2.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2,436,454 | 2,242,812 | 1,656,643 | 1,619,045 | 1,360,226 | 1,552,264 | 1,336,069 | 1,435,946 | 1,144,159 | 1,353,884 | 1,150,078 | 1,139,126 | 1,103,888 | 952,905 | 867,275 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 1,082,181 | 1,000,100 | 691,618 | 700,100 | 541,866 | 654,773 | 610,191 | 540,256 | 692,824 | 615,373 | |||||
Gross Profit | 1,354,273 | 1,242,712 | 965,025 | 918,945 | 818,360 | 897,491 | 725,878 | 895,690 | 451,335 | 738,511 | |||||
Admin Expenses | 245,186 | 227,260 | 180,523 | 192,040 | 183,017 | 177,154 | 190,415 | 298,196 | 173,696 | 161,137 | |||||
Operating Profit | 1,109,087 | 1,015,452 | 784,502 | 726,905 | 635,343 | 720,337 | 535,463 | 597,494 | 277,639 | 577,374 | 482,741 | 493,243 | 459,633 | 357,899 | 346,554 |
Interest Payable | 1,072,869 | 1,087,404 | 1,113,627 | 1,138,419 | 1,175,965 | 1,184,488 | 1,195,535 | 1,216,423 | 1,266,615 | 1,273,516 | 1,278,056 | 1,295,053 | 1,310,203 | 1,317,315 | 1,326,475 |
Interest Receivable | 850,289 | 819,381 | 821,845 | 852,482 | 897,830 | 921,844 | 940,595 | 1,138,100 | 1,001,800 | 1,020,808 | 1,042,207 | 1,060,226 | 1,078,805 | 1,095,829 | 1,096,221 |
Pre-Tax Profit | 886,507 | 747,429 | 492,720 | 440,968 | 357,208 | 457,693 | 280,523 | 619,171 | 12,824 | 324,666 | 246,892 | 258,416 | 228,235 | 136,413 | 116,300 |
Tax | -221,678 | -142,976 | -91,546 | -84,350 | -107,271 | -70,285 | -192,355 | -98,944 | -5,400 | -68,304 | -56,785 | -62,020 | -59,341 | -38,196 | -32,564 |
Profit After Tax | 664,829 | 604,453 | 401,174 | 356,618 | 249,937 | 387,408 | 88,168 | 520,227 | 7,424 | 256,362 | 190,107 | 196,396 | 168,894 | 98,217 | 83,736 |
Dividends Paid | 206,510 | 405,158 | 174,095 | 57,801 | 175,332 | 105,838 | 424,735 | 115,172 | 271,076 | 212,021 | 162,505 | 300,228 | 301,000 | ||
Retained Profit | 458,319 | 199,295 | 227,079 | 298,817 | 74,605 | 281,570 | -336,567 | 405,055 | 7,424 | -14,714 | -21,914 | 33,891 | -131,334 | 98,217 | -217,264 |
Employee Costs | |||||||||||||||
Number Of Employees | |||||||||||||||
EBITDA* | 1,109,087 | 1,015,452 | 784,502 | 726,905 | 635,343 | 720,337 | 535,463 | 597,494 | 277,639 | 577,374 | 482,741 | 493,243 | 459,633 | 357,899 | 346,554 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||||||||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | 12,639,654 | 13,376,742 | 14,572,001 | 15,323,975 | 16,120,844 | 15,544,308 | 16,061,892 | 16,551,734 | 17,012,444 | 17,447,876 | 17,862,476 | 18,254,829 | 18,626,130 | 18,977,507 | 19,310,030 |
Total Fixed Assets | 12,639,654 | 13,376,742 | 14,572,001 | 15,323,975 | 16,120,844 | 15,544,308 | 16,061,892 | 16,551,734 | 17,012,444 | 17,447,876 | 17,862,476 | 18,254,829 | 18,626,130 | 18,977,507 | 19,310,030 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 367,076 | 489,835 | 724,336 | 438,108 | 414,600 | 392,353 | 371,301 | 351,377 | 332,523 | 314,644 | |||||
Group Debtors | 240,735 | 240,735 | |||||||||||||
Misc Debtors | 4,595,299 | 4,401,724 | 3,944,526 | 3,660,527 | 3,368,491 | 2,623,123 | 1,827,624 | 1,975,964 | 2,203,208 | 2,357,165 | 913,954 | 838,696 | 638,170 | 446,497 | 302,349 |
Cash | 2,405,122 | 2,255,609 | 2,193,197 | 1,901,916 | 3,576,918 | 3,133,696 | 2,730,658 | 2,212,876 | 2,161,333 | 1,963,381 | 1,705,390 | 1,584,284 | 1,420,320 | 1,362,009 | 984,034 |
misc current assets | |||||||||||||||
total current assets | 7,367,497 | 6,657,333 | 6,137,723 | 5,562,443 | 6,945,409 | 5,756,819 | 5,048,117 | 5,153,911 | 5,043,384 | 4,735,146 | 3,011,697 | 2,794,281 | 2,409,867 | 2,141,029 | 1,601,027 |
total assets | 20,007,151 | 20,034,075 | 20,709,724 | 20,886,418 | 23,066,253 | 21,301,127 | 21,110,009 | 21,705,645 | 22,055,828 | 22,183,022 | 20,874,173 | 21,049,110 | 21,035,997 | 21,118,536 | 20,911,057 |
Bank overdraft | 554,692 | 583,766 | 554,415 | 325,432 | 444,551 | 325,432 | 362,644 | 325,432 | 260,081 | 243,312 | |||||
Bank loan | 251,203 | 238,427 | |||||||||||||
Trade Creditors | 134,654 | 115,813 | 135,652 | 60,326 | 182,578 | 141,216 | 106,646 | 140,832 | 124,277 | 75,929 | 37,990 | 70,593 | 43,090 | 68,823 | 46,669 |
Group/Directors Accounts | 57,715 | 57,715 | 56,945 | 56,945 | 57,715 | 56,733 | 56,327 | 57,577 | 58,484 | 57,715 | 56,460 | ||||
other short term finances | 242,561 | 198,783 | 145,612 | ||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 1,799,198 | 1,641,030 | 1,396,643 | 1,256,889 | 2,959,308 | 1,150,357 | 1,030,773 | 737,807 | 1,747,439 | 461,148 | 1,353,122 | 1,250,838 | 1,127,885 | 869,442 | 651,991 |
total current liabilities | 2,546,259 | 2,398,324 | 2,143,655 | 1,699,592 | 3,644,152 | 1,673,738 | 1,556,390 | 1,261,648 | 2,190,281 | 780,389 | 1,700,030 | 1,616,318 | 1,413,536 | 1,137,048 | 844,272 |
loans | 14,778,603 | 15,360,726 | 15,944,473 | 16,650,617 | 16,968,833 | 22,666,130 | 22,903,503 | 24,390,662 | 24,816,160 | 18,882,963 | 18,950,547 | 19,187,282 | 19,410,842 | 19,638,535 | 19,822,049 |
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 617,342 | 821,557 | 3,005,017 | 4,696,547 | 5,832,735 | 5,993,377 | |||||||||
provisions | 1,230,818 | ||||||||||||||
total long term liabilities | 15,395,945 | 16,182,283 | 18,949,490 | 21,347,164 | 22,801,568 | 22,666,130 | 22,903,503 | 24,390,662 | 24,816,160 | 26,107,158 | 18,950,547 | 19,187,282 | 19,410,842 | 19,638,535 | 19,822,049 |
total liabilities | 17,942,204 | 18,580,607 | 21,093,145 | 23,046,756 | 26,445,720 | 24,339,868 | 24,459,893 | 25,652,310 | 27,006,441 | 26,887,547 | 20,650,577 | 20,803,600 | 20,824,378 | 20,775,583 | 20,666,321 |
net assets | 2,064,947 | 1,453,468 | -383,421 | -2,160,338 | -3,379,467 | -3,038,741 | -3,349,884 | -3,946,665 | -4,950,613 | -4,704,525 | 223,596 | 245,510 | 211,619 | 342,953 | 244,736 |
total shareholders funds | 2,064,947 | 1,453,468 | -383,421 | -2,160,338 | -3,379,467 | -3,038,741 | -3,349,884 | -3,946,665 | -4,950,613 | -4,704,525 | 223,596 | 245,510 | 211,619 | 342,953 | 244,736 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 1,109,087 | 1,015,452 | 784,502 | 726,905 | 635,343 | 720,337 | 535,463 | 597,494 | 277,639 | 577,374 | 482,741 | 493,243 | 459,633 | 357,899 | 346,554 |
Depreciation | |||||||||||||||
Amortisation | |||||||||||||||
Tax | -221,678 | -142,976 | -91,546 | -84,350 | -107,271 | -70,285 | -192,355 | -98,944 | -5,400 | -68,304 | -56,785 | -62,020 | -59,341 | -38,196 | -32,564 |
Stock | |||||||||||||||
Debtors | -176,437 | -738,061 | -467,975 | -504,833 | 1,321,904 | -211,920 | -1,113,418 | -401,726 | -325,146 | 1,050,858 | -296,043 | -150,851 | -140,850 | -170,496 | 19,927,023 |
Creditors | 18,841 | -19,839 | 75,326 | -122,252 | 41,362 | 34,570 | -34,186 | 16,555 | 48,348 | 37,939 | -32,603 | 27,503 | -25,733 | 22,154 | 46,669 |
Accruals and Deferred Income | 158,168 | 244,387 | 139,754 | -1,702,419 | 1,808,951 | 119,584 | 292,966 | -1,009,632 | 1,286,291 | -891,974 | 102,284 | 122,953 | 258,443 | 217,451 | 651,991 |
Deferred Taxes & Provisions | -1,230,818 | 1,230,818 | |||||||||||||
Cash flow from operations | 1,240,855 | 1,835,085 | 1,376,011 | -677,283 | 1,056,481 | 1,016,126 | 1,715,306 | -92,801 | 701,206 | -165,005 | 791,680 | 732,530 | 773,852 | 729,804 | -18,914,373 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | -251,203 | 12,776 | 238,427 | ||||||||||||
Group/Directors Accounts | 770 | -770 | 982 | 406 | -1,250 | -907 | 58,484 | -57,715 | 1,255 | 56,460 | |||||
Other Short Term Loans | -242,561 | 43,778 | 53,171 | 145,612 | |||||||||||
Long term loans | -582,123 | -583,747 | -706,144 | -318,216 | -5,697,297 | -237,373 | -1,487,159 | -425,498 | 5,933,197 | -67,584 | -236,735 | -223,560 | -227,693 | -183,514 | 19,822,049 |
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -204,215 | -2,183,460 | -1,691,530 | -1,136,188 | 5,832,735 | -5,993,377 | 5,993,377 | ||||||||
share issue | |||||||||||||||
interest | -222,580 | -268,023 | -291,782 | -285,937 | -278,135 | -262,644 | -254,940 | -78,323 | -264,815 | -252,708 | -235,849 | -234,827 | -231,398 | -221,486 | -230,254 |
cash flow from financing | -855,758 | -1,396,866 | -1,139,618 | -820,799 | -557,046 | -470,038 | -810,001 | 94,165 | -520,023 | 450,760 | -458,553 | -406,061 | -415,313 | -351,829 | 20,199,407 |
cash and cash equivalents | |||||||||||||||
cash | 149,513 | 62,412 | 291,281 | -1,675,002 | 443,222 | 403,038 | 517,782 | 51,543 | 197,952 | 257,991 | 121,106 | 163,964 | 58,311 | 377,975 | 984,034 |
overdraft | -29,074 | 29,351 | 228,983 | -119,119 | 119,119 | -37,212 | 37,212 | 65,351 | 16,769 | 243,312 | |||||
change in cash | 178,587 | 33,061 | 62,298 | -1,555,883 | 324,103 | 440,250 | 480,570 | -13,808 | 181,183 | 14,679 | 121,106 | 163,964 | 58,311 | 377,975 | 984,034 |
elgin health (gartnavel) limited Credit Report and Business Information
Elgin Health (gartnavel) Limited Competitor Analysis

Perform a competitor analysis for elgin health (gartnavel) limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other small companies, companies in EH3 area or any other competitors across 12 key performance metrics.
elgin health (gartnavel) limited Ownership
ELGIN HEALTH (GARTNAVEL) LIMITED group structure
Elgin Health (Gartnavel) Limited has no subsidiary companies.
Ultimate parent company
2 parents
ELGIN HEALTH (GARTNAVEL) LIMITED
SC271565
elgin health (gartnavel) limited directors
Elgin Health (Gartnavel) Limited currently has 3 directors. The longest serving directors include Mr Michael Donn (Oct 2014) and Mr Frank Laing (Mar 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Michael Donn | 53 years | Oct 2014 | - | Director | |
Mr Frank Laing | England | 37 years | Mar 2019 | - | Director |
Mr Peter Johnstone | United Kingdom | 59 years | Jan 2024 | - | Director |
P&L
March 2024turnover
2.4m
+9%
operating profit
1.1m
+9%
gross margin
55.6%
+0.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
2.1m
+0.42%
total assets
20m
0%
cash
2.4m
+0.07%
net assets
Total assets minus all liabilities
elgin health (gartnavel) limited company details
company number
SC271565
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
August 2004
age
21
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
robertson health (gartnavel) limited (April 2016)
mm&s (4006) limited (January 2005)
accountant
-
auditor
JOHNSTON CARMICHAEL LLP
address
c/o resolis limited, exchange tower, 11th floor, edinburgh, EH3 8EG
Bank
BANK OF SCOTLAND
Legal Advisor
-
elgin health (gartnavel) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to elgin health (gartnavel) limited. Currently there are 4 open charges and 0 have been satisfied in the past.
elgin health (gartnavel) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELGIN HEALTH (GARTNAVEL) LIMITED. This can take several minutes, an email will notify you when this has completed.
elgin health (gartnavel) limited Companies House Filings - See Documents
date | description | view/download |
---|